Thanks I am now in personal communication with Frank anyway!
Dan
-----Original Message-----
From: peter dalgaard <pdalgd at gmail.com>
Sent: 14 March 2019 10:37
To: Jackson, Daniel <daniel.jackson1 at astrazeneca.com>
Cc: r-help at r-project.org
Subject: Re: [R] Rank ANCOVA
1. This is the R-help mailing list, not "Frank and Dennis"
2. You seem to be referring to two posts from July 2010 by Frank Harrell and
Dennis Fisher.
-pd
> On 13 Mar 2019, at 12:06 , Jackson, Daniel <daniel.jackson1 at
astrazeneca.com> wrote:
>
> Hi Frank and Dennis
>
> I am in a similar situation but I would prefer to use a proportional odds
model. 2 questions.
>
>
> 1. Has rank ancova been implemented in R now, despite its short comings?
> 2. Where has it been shown to yield unreliable analyses? I would like
this evidence (which I believe but I would like to convince others!).
>
> Thanks, Dan
> ________________________________
>
> AstraZeneca UK Limited is a company incorporated in
> Engl...{{dropped:16}}
>
> ______________________________________________
> R-help at r-project.org mailing list -- To UNSUBSCRIBE and more, see
> https://stat.ethz.ch/mailman/listinfo/r-help
> PLEASE do read the posting guide
> http://www.R-project.org/posting-guide.html
> and provide commented, minimal, self-contained, reproducible code.
--
Peter Dalgaard, Professor,
Center for Statistics, Copenhagen Business School Solbjerg Plads 3, 2000
Frederiksberg, Denmark
Phone: (+45)38153501
Office: A 4.23
Email: pd.mes at cbs.dk Priv: PDalgd at gmail.com
________________________________
AstraZeneca UK Limited is a company incorporated in England and Wales with
registered number:03674842 and its registered office at 1 Francis Crick Avenue,
Cambridge Biomedical Campus, Cambridge, CB2 0AA.
This e-mail and its attachments are intended for the above named recipient only
and may contain confidential and privileged information. If they have come to
you in error, you must not copy or show them to anyone; instead, please reply to
this e-mail, highlighting the error to the sender and then immediately delete
the message. For information about how AstraZeneca UK Limited and its affiliates
may process information, personal data and monitor communications, please see
our privacy notice at www.astrazeneca.com<https://www.astrazeneca.com>